已收盘 08-01 16:00:00 美东时间
+0.030
+0.24%
<p>LifeVantage Corporation® (Nasdaq: LFVN), a health and wellness company, announced its upcoming launch in Iceland in September. The launch includes products like Protandim® Nrf2 Synergizer, MindBody GLP-1 System™, TrueScience® Liquid Collagen, and LifeVantage® ProBio, as well as curated wellness stacks. The company also offers a business opportunity through its Evolve Compensation Plan. CEO Steve Fife expressed excitement about this expansion, ...
07-24 12:00
LifeVantage's MindBody GLP-1 System achieves over 200% average increase in GLP-1 levels, supporting fat loss, appetite control, and improved body composition. Participants lost an average of 11 pounds over 12 weeks, with some losing up to 25 pounds. The system also reduced sugar and fast-food cravings by 95% and 89%, respectively. These results demonstrate the product's effectiveness in promoting natural wellness and healthier eating habits.
07-22 12:00
LifeVantage Corporation held its global Activate 2025 event on July 12, introducing the "Summer in the Fast Lane" campaign to drive business growth and innovation in the direct selling model. The campaign features new sales incentives, including exclusive mini trips and the launch of the High Speed Health Stack, a product组合 focusing on weight management and wellness. The event also announced the next U.S. Momentum Academy in Dallas. Steve Fife, C...
07-15 12:00
Lifevantage shares are trading lower following a Q3 sales miss and after the co...
05-07 05:03
Shares of ReShape Lifesciences Inc. (NASDA: RSLS) rose sharply in today's pre-m...
04-10 17:26
There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts...
02-25 01:00
LifeVantage (NASDAQ:LFVN) declares $0.04/share quarterly dividend, in line with previous. Forward yield 0.7% Payable March 17; for shareholders of record March 3; ex-div March 3. See LFVN Dividend Sco...
02-06 05:51
Lifevantage shares are trading lower. The company reported Q2 financial results.
02-06 05:39
Lifevantage (NASDAQ:LFVN) affirms FY2025 sales outlook from $235.00 million-245.00 million to $235.00 million-245.00 million vs $238.48 million estimate.
02-06 05:38
Companies Reporting Before The Bell • Aurora Cannabis (NASDAQ:ACB) is likely to...
02-05 16:32